Skip to Main Content

Paper Details

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma.
Oncotarget
35
2018
C9orf64, CDH1, CDH17, CLCA1, CLIC3, CTNNB1, EPCAM, FAM96A, FN1, GLUT1, LGALS4, MMP8, MMP9, P4HA2, PDAC, PRTN3, Pancreatic ductal adenocarcinoma, TCF1, THBS1, TP53, TPPP3, VIL1, formalin, malignancy, pancreatic ductal adenocarcinoma, patients
Author NameAffiliation
Krzysztof Paw??owskiWarsaw University of Life Sciences
Krzysztof Paw??owskiLund University
Melinda RezeliClinical Protein Science and Imaging, Lund University
Gy??rgy Marko-VargaClinical Protein Science and Imaging, Lund University
Gy??rgy Marko-VargaClinical Protein Science and Imaging, Lund University
  • 1 - 5

Datasets

Release 1.2